HOOKIPA Pharma Announces First Person Dosed in Phase 1B Clinical Trial of Hb-500 for the Treatment of Hiv
hookipa pharma宣佈Hb-500用於治療HIV的1B期臨床試驗已經給第一位個體注射
HOOKIPA Pharma Announces First Person Dosed in Phase 1B Clinical Trial of Hb-500 for the Treatment of Hiv
hookipa pharma宣佈Hb-500用於治療HIV的1B期臨床試驗已經給第一位個體注射
譯文內容由第三人軟體翻譯。